Brevel is an Israel-based plant-based ingredients startup that develops cultivation technology for microalgae-based alternative proteins for various applications.
The company claims they have solved issues associated with microalgae as a protein source such as high production cost, low nutritional profile, and palatable taste by utilizing proprietary technology that combines fermentation and photosynthesis in indoor, fully automated reactors. Compared to existing solutions, this method is claimed to increase yield per land by 200x and reduce cost by 90%. According to Brevel, the resulting product is color and taste-neutral while being comparable to other leading alternatives such as soy and pea.
The company plans to build two large facilities (5,000 and 900,000 liters) and have its products on shelves by 2024.
Funding and financials
In July 2023 , Brevel raised USD 18.5 million in a seed funding round led by NevaTeam Partners, with participation from the European Union's EIC Fund and others. The funding included USD 8.4 million raised in June 2022 , converted from grants and convertible loans into equity. The funding was earmarked for the further development of its protein and expansion of operations.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.